发泡胶固定下鼻咽癌调强放疗颈部摆位误差的剂量学影响OA
Dosimetric impact of interfractional cervical setup errors in nasopharyngeal carcinoma patients undergoing IMRT with foam immobilization
目的 探讨基于发泡胶固定的鼻咽癌(nasopharyngeal carcinoma,NPC)调强放射治疗(intensity-modulated radiation therapy,IMRT)中分次间颈部摆位误差的变化规律及其对计划靶区(planning target volume,PTV)剂量分布的影响,为临床优化外放边界提供依据.方法 回顾性分析2023年10月至2024年5月收治的60例接受IMRT的鼻咽癌患者临床资料.所有患者采用头颈肩热塑膜联合发泡胶固定.根据影像验证频率分为A组(n=30,隔天验证)和B组(n=30,第10、20、30次治疗时验证).利用机载影像(On-Board Ima-ger,OBI)系统获取千伏级(kV)验证图像,采用二维-三维配准方法测量颈部在垂直(VRT)、纵向(LNG)和横向(LAT)方向的摆位误差.基于全部误差数据构建误差分布模型,采用剂量重建方法模拟实际照射剂量,评估误差对临床靶区(clinical target volume,CTV)和危及器官(organs at risk,OARs)的剂量学影响.结果 共纳入分析60例患者,获取A组1 350次、B组270次配准数据.两组患者的基线资料差异无统计学意义(P>0.05).摆位误差随治疗进程呈动态变化:治疗后期(>20次)误差显著大于前期(P<0.05).A组和B组在VRT、LAT方向的随机误差(σ)均>3 mm.剂量学分析显示,尽管多数情况下3~5 mm的误差未导致CTV剂量学参数(D95%)的显著变化,但误差≥5 mm时,淋巴结大体肿瘤体积(Gross Tumour Volume of lymph Nodes,GTVnd)的Dmax和Dmean均出现下降,且差异有统计学意义(P<0.05).OARs受量在所有模拟场景下均保持在临床可接受范围内.基于全部误差数据计算,推荐颈部PTV外放边界为VRT/LAT方向4.5 mm、LNG方向3.5 mm.结论 在IMRT治疗中后期,颈部摆位误差随解剖结构变化而增大.尽管当前固定技术下多数分次误差可控,但大误差仍可能导致靶区剂量不足.建议在治疗中后期加强图像引导频次,并采用优化的外放边界以平衡靶区覆盖与OARs保护.
Objective To investigate the characteristics of interfractional cervical setup errors and their dosimet-ric impact on the planning target volume(PTV)in nasopharyngeal carcinoma(NPC)patients undergoing intensity-mod-ulated radiation therapy(IMRT)with foam-based immobilization,and to provide evidence for optimizing PTV margin ex-pansion.Methods Clinical data of 60 NPC patients treated with IMRT between October 2023 and May 2024 were retro-spectively analyzed.All patients were immobilized using a thermoplastic head-neck-shoulder mask combined with foam fixation.According to image verification frequency,patients were divided into group A(n=30,verification every other fraction)and group B(n=30,verification at the 10th,20th,and 30th fractions).Kilovoltage(kV)images were ac-quired using an on-board imager(OBI)system,and cervical setup errors in the vertical(VRT),longitudinal(LNG),and lateral(LAT)directions were measured using a 2D-3D registration method.Error distribution models were estab-lished based on all setup data,and dose reconstruction was performed to simulate the delivered dose,evaluating dosimetric effects on the clinical target volume(CTV)and organs at risk(OARs).Results A total of 1,620 image registrations were analyzed,including 1,350 in group A and 270 in group B.No significant differences in baseline characteristics were observed between the two groups(P>0.05).Cervical setup errors demonstrated dynamic changes over the treatment course,with significantly larger errors in the late treatment phase(>20 fractions)compared with the early phase(P<0.05).In both groups,random errors(σ)in the VRT and LAT directions exceeded 3 mm.Dosimetric analysis showed that setup errors of 3-5 mm did not result in significant changes in CTV dose coverage(D95%)in most scenarios.How-ever,when setup errors were≥5 mm,both the maximum dose(Dmax)and mean dose(Dmean)of the gross tumor vol-ume of lymph nodes(GTVnd)were significantly reduced(P<0.05).Dose constraints for OARs remained within clini-cally acceptable limits across all simulated scenarios.Based on comprehensive error analysis,recommended cervical PTV margins were 4.5 mm in the VRT and LAT directions and 3.5 mm in the LNG direction.Conclusion During IMRT for NPC,interfractional cervical setup errors increase in the middle to late treatment stages,likely due to anatomical changes.Although most setup deviations are manageable with current immobilization techniques,large errors may lead to insufficient target dose coverage.Increased image guidance in later treatment stages and optimized PTV margin expansion are recom-mended to balance target coverage and OAR protection.
郭旋;姜海燕;熊燕;迟锋;姚文燕;许森奎
中山大学肿瘤防治中心放疗科,华南肿瘤学国家重点实验室,肿瘤医学协同创新中心,广东省鼻咽癌诊治研究重点实验室(广东 广州 510060)中山大学肿瘤防治中心放疗科,华南肿瘤学国家重点实验室,肿瘤医学协同创新中心,广东省鼻咽癌诊治研究重点实验室(广东 广州 510060)中山大学肿瘤防治中心放疗科,华南肿瘤学国家重点实验室,肿瘤医学协同创新中心,广东省鼻咽癌诊治研究重点实验室(广东 广州 510060)中山大学肿瘤防治中心放疗科,华南肿瘤学国家重点实验室,肿瘤医学协同创新中心,广东省鼻咽癌诊治研究重点实验室(广东 广州 510060)中山大学肿瘤防治中心放疗科,华南肿瘤学国家重点实验室,肿瘤医学协同创新中心,广东省鼻咽癌诊治研究重点实验室(广东 广州 510060)中山大学肿瘤防治中心放疗科,华南肿瘤学国家重点实验室,肿瘤医学协同创新中心,广东省鼻咽癌诊治研究重点实验室(广东 广州 510060)
医药卫生
鼻咽癌调强放射治疗摆位误差发泡胶剂量分析
nasopharyngeal carcinomaintensity-modulated radiation therapysetup errorfoam immobiliza-tiondosimetric analysis
《广东医学》 2026 (4)
543-549,7
广东省医学科研基金项目(A2020621)
评论